| CD163 and inflammation: biological, diagnostic, and therapeutic aspects A Etzerodt, SK Moestrup Antioxidants & redox signaling 18 (17), 2352-2363, 2013 | 536 | 2013 |
| Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression P Goossens, J Rodriguez-Vita, A Etzerodt, M Masse, O Rastoin, ... Cell metabolism 29 (6), 1376-1389. e4, 2019 | 302 | 2019 |
| Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163 A Etzerodt, MB Maniecki, K Møller, HJ Møller, SK Moestrup Journal of leukocyte biology 88 (6), 1201-1205, 2010 | 234 | 2010 |
| Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer A Etzerodt, M Moulin, TK Doktor, M Delfini, N Mossadegh-Keller, ... Journal of Experimental Medicine 217 (4), 2020 | 218 | 2020 |
| The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging JH Thomsen, A Etzerodt, P Svendsen, SK Moestrup Oxidative medicine and cellular longevity 2013, 2013 | 184 | 2013 |
| Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone JH Graversen, P Svendsen, F Dagnæs-Hansen, J Dal, G Anton, ... Molecular Therapy 20 (8), 1550-1558, 2012 | 169 | 2012 |
| Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression A Etzerodt, K Tsalkitzi, M Maniecki, W Damsky, M Delfini, E Baudoin, ... Journal of Experimental Medicine 216 (10), 2394-2411, 2019 | 168 | 2019 |
| Obesity alters adipose tissue macrophage iron content and tissue iron distribution JS Orr, A Kennedy, EK Anderson-Baucum, CD Webb, SC Fordahl, ... Diabetes 63 (2), 421-432, 2014 | 167 | 2014 |
| Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163 A Etzerodt, MB Maniecki, JH Graversen, HJ Møller, VP Torchilin, ... Journal of controlled release 160 (1), 72-80, 2012 | 134 | 2012 |
| Tumor‐promoting macrophages induce the expression of the macrophage‐specific receptor CD163 in malignant cells MB Maniecki, A Etzerodt, BP Ulhøi, T Steiniche, M Borre, L Dyrskjøt, ... International journal of cancer 131 (10), 2320-2331, 2012 | 121 | 2012 |
| Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson's disease model N Tentillier, A Etzerodt, MN Olesen, FS Rizalar, J Jacobsen, D Bender, ... Journal of Neuroscience 36 (36), 9375-9390, 2016 | 104 | 2016 |
| Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption A Etzerodt, M Kjolby, MJ Nielsen, M Maniecki, P Svendsen, SK Moestrup Antioxidants & redox signaling 18 (17), 2254-2263, 2013 | 97 | 2013 |
| Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages A Etzerodt, MR Rasmussen, P Svendsen, A Chalaris, J Schwarz, I Galea, ... Journal of Biological Chemistry 289 (2), 778-788, 2014 | 87 | 2014 |
| Antibody-directed glucocorticoid targeting to CD163 in M2-type macrophages attenuates fructose-induced liver inflammatory changes P Svendsen, JH Graversen, A Etzerodt, H Hager, R Røge, H Grønbæk, ... Molecular Therapy Methods & Clinical Development 4, 50-61, 2017 | 80 | 2017 |
| STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes MN Andersen, A Etzerodt, JH Graversen, LC Holthof, SK Moestrup, ... Cancer Immunology, Immunotherapy 68, 489-502, 2019 | 52 | 2019 |
| The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms MC Nielsen, MN Andersen, N Rittig, S Rødgaard-Hansen, H Grønbæk, ... Journal of leukocyte biology 106 (5), 1129-1138, 2019 | 47 | 2019 |
| Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’in plasma A Etzerodt, RMG Berg, RR Plovsing, MN Andersen, M Bebien, ... Scientific Reports 7 (1), 40286, 2017 | 46 | 2017 |
| Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface … MB Maniecki, A Etzerodt, SK Moestrup, HJ Møller, JH Graversen Immunobiology 216 (8), 882-890, 2011 | 45 | 2011 |
| Targeting dexamethasone to macrophages in a porcine endotoxemic model A Granfeldt, CL Hvas, JH Graversen, PA Christensen, MD Petersen, ... Critical Care Medicine 41 (11), e309-e318, 2013 | 41 | 2013 |
| Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson's disease SK Nissen, SA Ferreira, MC Nielsen, C Schulte, K Shrivastava, D Hennig, ... Movement Disorders 36 (4), 963-976, 2021 | 39 | 2021 |
